Genetic accessibility, not superior fitness, determines which anti-HBs antibody escape variants are selected in patients.
Yu Y, Michailidis E, Seifert LL, Zhang M, Zou C, Freije CA, Dangas G, Athanasiadis A, Puschnik A, Hanson A, Rocha E, Chen YP, Hong X, Quirk C, Zhou Y, Schmid MA, Lempp FA, Rice CM, Schneider WM, de Jong YP
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.